The machines that are utilized to remove secretions from the airways are known as oscillating positive expiratory pressure (OPEP) devices. People with chronic respiratory conditions like COPD, cystic fibrosis, and chronic bronchitis among others can benefit from it. The device is used to remove excess mucus that these illnesses produce. It facilitates breathing and helps to relax the lungs’ walls.
Download Sample PDF Of This Report:
https://www.globalinsightservices.com/request-sample/GIS10444/
Market Trends and Drivers
The increasing prevalence of cystic fibrosis and chronic obstructive pulmonary disease (COPD) has led to a surge in demand for mucous clearing devices, with oscillating positive expiratory pressure (OPEP) devices spearheading the growth of the market. These conditions often result in the accumulation of thick mucus in the airways, leading to breathing difficulties and decreased lung function. OPEP devices offer an effective solution by generating oscillations during exhalation, which helps to mobilize and loosen the mucus, facilitating its removal and improving airway clearance. As awareness of the benefits of these devices continues to spread among healthcare professionals and patients alike, the OPEP devices market is poised to experience significant expansion to meet the rising needs of individuals seeking better management of cystic fibrosis and COPD.
Major Players in the Global Oscillating Positive Expiratory Pressure Devices Market
The major players studied in the global oscillating positive expiratory pressure devices market are AirPhysio, Allergan plc., D-R Burton Healthcare, Medica Holdings, LLC., Monaghan Medical Corporation, PARI GmbH, R. Cegla GmbH & Co. KG, Smiths Medical, Inc., and WyMedical Pty Ltd among others.
COVID-19 Impact
The COVID-19 pandemic has had a significant impact on the oscillating positive expiratory pressure (OPEP) devices market. As the virus primarily targets the respiratory system, there has been a heightened focus on respiratory care and management, driving the demand for OPEP devices. These devices, which aid in clearing mucus and improving lung function, have been increasingly adopted in both clinical settings and home care, as patients and healthcare providers recognize their benefits in mitigating the effects of COVID-19 and other respiratory illnesses. Additionally, the growing awareness of the importance of respiratory health and the need to bolster healthcare infrastructure have further fueled the market’s expansion. However, disruptions in the global supply chain, regulatory challenges, and economic uncertainties during the pandemic have posed some hurdles to the market’s growth. Nonetheless, the long-term prospects for the OPEP devices market remain promising as the world adapts to a new normal with a greater emphasis on respiratory well-being.
Recent Developments
In April 2021, Smiths Medical launched the acapella choice blue vibratory PEP therapy system. Acapella is designed to aid in removing secretions for patients with cystic fibrosis, chronic obstructive pulmonary disease (COPD), asthma, lung disease with secretory problems, and patients with atelectasis.
In May 2021, Monaghan Medical Corporation and Captis announced their agreement to a three year contract creating a partnership between the industry leaders. The sole source agreement recognizes the value of Monaghan’s patient outcome evidence and gold standard medical devices, with Captis’ desire to drive process efficiencies and value driven healthcare spending.
In January 2021, AirPhysio, indicated for use as a Positive Expiratory Pressure (PEP) Device, received approval from the United States Food and Drug Administration.
In February 2020, Smiths Medical Announced Launch Of Oscillatory Positive Expiratory Pressure Educational Programme On Doctors.net.uk.
Procure Complete Report (pdf with Insights, Charts, Tables, and Figures)
https://www.globalinsightservices.com/checkout/single_user/GIS10444/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: [email protected]
Phone: +1–833–761–1700
Website: https://www.globalinsightservices.com/